Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 44 results.
User Information
Export Records
  1. 1.   HTLV-1 p13 Protein Hijacks Macrophage Polarization and Promotes T-Cell Recruitment
  2. Moles, Ramona; Omsland, Maria; Pise-Masison, Cynthia A; Subleski,Jeffrey; McVicar,Daniel; Sarkis, Sarkis; Gutowska, Anna; Schifanella, Luca; Doster, Melvin; Washington-Parks, Robyn; Ciminale, Vincenzo; Franchini, Genoveffa
  3. Viruses. 2025, Mar 26; 17(4): 471.
  1. 2.   Complete Rescue of HTLV-1p12KO Infectivity by Depletion of Monocytes Together with NK and CD8+ T Cells
  2. Gutowska, Anna; Sarkis, Sarkis; Rahman, Mohammad Arif; Goldfarbmuren,Kate; Moles, Ramona; Bissa, Massimiliano; Doster, Melvin; Washington-Parks, Robyn; McKinnon, Katherine; Silva de Castro, Isabela; Schifanella, Luca; Franchini, Genoveffa; Pise-Masison, Cynthia A
  3. Pathogens (Basel, Switzerland). 2024, Mar 29; 13(4):
  1. 3.   Molecular Aspects of HTLV-1 Entry: Functional Domains of the HTLV-1 Surface Subunit (SU) and Their Relationships to the Entry Receptors
  2. Jones, K. S.; Lambert, S.; Bouttier, M.; Benit, L.; Ruscetti, F. W.; Hermine, O.; Pique, C.
  3. Viruses-Basel. 2011, Jun; 3(6): 794-810.
  1. 4.   Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy
  2. Sasaki, D.; Imaizumi, Y.; Hasegawa, H.; Osaka, A.; Tsukasaki, K.; Choi, Y. L.; Mano, H.; Marquez, V. E.; Hayashi, T.; Yanagihara, K.; Moriwaki, Y.; Miyazaki, Y.; Kamihira, S.; Yamada, Y.
  3. Haematologica-the Hematology Journal. 2011, May; 96(5): 712-719.
  1. 5.   Ethnoepidemiology of HTLV-1 related diseases: Ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal
  2. Sonoda, S.; Li, H. C. A.; Tajima, K.
  3. Cancer Science. 2011, Feb; 102(2): 295-301.
  1. 6.   Current concepts regarding the HTLV-1 receptor complex
  2. Ghez, D.; Lepelletier, Y.; Jones, K. S.; Pique, C.; Hermine, O.
  3. Retrovirology. 2010, Nov; 7: 11.
  1. 7.   Hematopoietic Immortalizing Function of the NKL-Subclass Homeobox Gene TLX1
  2. Renn, L. A. Z.; Hawley, T. S.; Burkett, S.; Ramezani, A.; Riz, I.; Adlers, R. L.; Hickstein, D. D.; Hawley, R. G.
  3. Genes Chromosomes & Cancer. 2010, Feb; 49(2): 119-131.
  1. 8.   Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia
  2. Vinh, D. C.; Patel, S. Y.; Uzel, G.; Anderson, V. L.; Freeman, A. F.; Olivier, K. N.; Spalding, C.; Hughes, S.; Pittaluga, S.; Raffeld, M.; Sorbara, L. R.; Elloumi, H. Z.; Kuhns, D. B.; Turner, M. L.; Cowen, E. W.; Fink, D.; Long-Priel, D.; Hsu, A. P.; Ding, L.; Paulson, M. L.; Whitney, A. R.; Sampaio, E. P.; Frucht, D. M.; Deleo, F. R.; Holland, S. M.
  3. Blood. 2010, Feb; 115(8): 1519-1529.
  1. 9.   Aprotease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity
  2. Weldon, J. E.; Xiang, L. M.; Chertov, O.; Margulies, I.; Kreitman, R. J.; FitzGerald, D. J.; Pastan, I.
  3. Blood. 2009 113(16): 3792-3800.
  1. 10.   Preclinical Evaluation of an Anti-CD25 Monoclonal Antibody, 7G7/B6, Armed with the beta-Emitter, Yttrium-90, as a Radioimmunotherapeutic Agent for Treating Lymphoma
  2. Zhang, M. L.; Yao, Z. S.; Garmestani, K.; Yu, S.; Goldman, C. K.; Paik, C. H.; Brechbiel, M. W.; Carrasquillo, J. A.; Waldmann, T. A.
  3. Cancer Biotherapy and Radiopharmaceuticals. 2009 24(3): 303-309.
  1. 11.   The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20
  2. Shembade, N.; Harhaj, N. S.; Parvatiyar, K.; Copeland, N. G.; Jenkins, N. A.; Matesic, L. E.; Harhaj, E. W.
  3. Nature Immunology. 2008 9(3): 254-262.
  1. 12.   Hematologic and biochemical changes associated with human T lymphotropic virus type 1 infection in Jamaica: A report from the population-based blood donors study
  2. Chaturvedi, A. K.; Wilson, M.; Sanders-Lewis, K. A.; Katki, H. A.; Urquhart, N.; Walters, M. A.; Miley, W.; Cranston, B.; Hanchard, B.; Hisada, M.
  3. Clinical Infectious Diseases. 2007, Oct; 45(8): 975-982.
  1. 13.   Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types
  2. Goedert, J. J.; Li, H. C.; Gao, X. J.; Chatterjee, N.; Sonoda, S.; Biggar, R. J.; Cranston, B.; Kim, N.; Carrington, M.; Morgan, O.; Hanchard, B.; Hisada, M.
  3. International Journal of Cancer. 2007, Sep; 121(5): 1092-1097.
  1. 14.   Lessons learned fighting HIV can be applied to anti-cancer drug design
  2. Gustchina, A.; Jaskolski, M.; Wlodawer, A.
  3. Cell Cycle. 2006, MAR 1; 5(5): 463-464.
  1. 15.   Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase
  2. Mitchell, M. S.; Tozser, J.; Princler, G.; Lloyd, P. A.; Auth, A.; Derse, D.
  3. Journal of Biological Chemistry. 2006, FEB 17; 281(7): 3964-3971.
  1. 16.   Molecular replacement with pseudosymmetry and model dissimilarity: a case study
  2. Jaskolski, M.; Li, M.; Laco, G.; Gustchina, A.; Wlodawer, A.
  3. Acta Crystallographica Section D-Biological Crystallography. 2006, FEB; 62(Part 2): 208-215.
  1. 17.   A transcription inhibitor, Actinomycin D, enhances HIV-1 replication through an interleukin-6-dependent pathway
  2. Imamichi, T.; Conrads, T. P.; Zhou, M.; Liu, Y. X.; Adelsberger, J. W.; Veenstra, T. D.; Lane, H. C.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 1; 40(4): 388-397.
  1. 18.   Heparan sulfate Proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4(+) T cells
  2. Jones, K. S.; Petrow-Sadowski, C.; Bertolette, D. C.; Huang, Y.; Ruscetti, F. W.
  3. Journal of Virology. 2005, OCT; 79(20): 12692-12702.
  1. 19.   Cholesterol dependence of HTLV-I infection
  2. Wielgosz, M. M.; Rauch, D. A.; Jones, K. S.; Ruscetti, F. W.; Ratner, L.
  3. Aids Research and Human Retroviruses. 2005, JAN; 21(1): 43-50.
  1. 20.   Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta(1,2)
  2. Jones, K. S.; Akel, S.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Ruscetti, F. W.
  3. Journal of Immunology. 2005 174(7): 4262-4270.
  1. 21.   Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I
  2. Li, H. C.; Biggar, R. J.; Miley, W. J.; Maloney, E. M.; Cranston, B.; Hanchard, B.; Hisada, M.
  3. Journal of Infectious Diseases. 2004, OCT 1; 190(7): 1275-1278.
  1. 22.   Infectious transmission and replication of human T-cell leukemia virus type 1
  2. Derse, D.; Heidecker, G.; Mitchell, M.; Hill, S.; Lloyd, P.; Princler, G.
  3. Frontiers in Bioscience. 2004, SEP 1; 9: 2495-2499.
  1. 23.   HTLV-1-encoded p30(II) is a post-transcriptional negative regulator of viral replication
  2. Nicot, C.; Dundr, M.; Johnson, J. M.; Fullen, J. R.; Alonzo, N.; Fukumoto, R.; Princler, G. L.; Derse, D.; Misteli, T.; Franchini, G.
  3. Nature Medicine. 2004 10(2): 197-201.
  1. 24.   Suppression of tumor growth and cell proliferation by p13(II), a mitochondrial protein of human T cell leukemia virus type 1
  2. Silic-Benussi, M.; Cavallari, L.; Zorzan, T.; Rossi, E.; Hiraragi, H.; Rosato, A.; Horie, K.; Saggioro, D.; Lairmore, M. D.; Willems, L.; Chieco-Bianchi, L.; D'Agostino, D. M.; Ciminale, V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(17): 6629-6634.
  1. 25.   A novel retrovirus provides the cooperating oncogenic event(s) required to demonstrate the tumor suppressor activity of p15(Ink4b) in myeloid cells in vivo
  2. Wolff, L.; Garin, M. T.; Koller, R.; Bies, J.; Tessarollo, L.; Anver, M. R.; Powell, D.; Perella, C.
  3. Blood Cells Molecules and Diseases. 2004, JAN-FEB; 32(1): 226-231.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel